Boothbay Fund Management, LLC Amgen Inc Call Options Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $1.8 Million - $2.17 Million	6,700 Added 72.04%	16,000 $4.55 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $2.38 Million - $2.68 Million	9,300 New	9,300 $2.68 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $230,710 - $256,740	-1,000 Reduced 6.94%	13,400 $3.26 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $3.16 Million - $3.49 Million	14,400 New	14,400 $3.48 Million

3,054

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.